Clinical Trial Update: Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating serplulimab with chemotherapy as neoadjuvant therapy for limited-stage small cell lung cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: SCLC, Limited Stage | Phase 2 | Status: RECRUITING